JP2001095559A - Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganism - Google Patents
Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganismInfo
- Publication number
- JP2001095559A JP2001095559A JP27823799A JP27823799A JP2001095559A JP 2001095559 A JP2001095559 A JP 2001095559A JP 27823799 A JP27823799 A JP 27823799A JP 27823799 A JP27823799 A JP 27823799A JP 2001095559 A JP2001095559 A JP 2001095559A
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- solution
- aqueous solution
- coagulant
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】原液乃至検体より、目的の菌
を効率良く回収する助剤乃至この助剤を用いる菌回収方
法であり、食用有用菌、薬用有用菌、特に病原性微生
物、殊に抗酸菌を効率良く集菌する方法に関する。また
前記助剤は従来飲料水、産業廃液などの浄化薬剤として
用いられていたものを、菌凝集助剤として用途開発した
用途発明を含む発明に係るものである。TECHNICAL FIELD The present invention relates to an auxiliary agent for efficiently recovering a target bacterium from an undiluted solution or a specimen or a method for recovering a bacterium using this auxiliary agent. The present invention relates to a method for efficiently collecting acid bacteria. In addition, the auxiliary agent according to the present invention includes a use invention which has been conventionally developed as a bacterial coagulation auxiliary agent, which has been conventionally used as a purifying agent for drinking water, industrial waste liquid, and the like.
【0002】[0002]
【従来の技術】従来、この種の菌回収方法としては、遠
心沈殿させて、回収する方法が主流であるが、集菌効率
を向上させる方法としては専ら遠心力を上げることばか
り考えられている。遠心力を上げるには装置が大型化す
るだけでなく、設備が高価となり、有用性が減殺され
る。また遠心力を上げ過ぎると目的の菌が死滅してしま
うおそれがあり、遠心力をあげることは自ずと限界があ
る。また、昭和35年頃から電気泳動法も一部で用いら
れているが、術式が面倒なのと装置自体が高価である
し、この方法自体菌集収率を向上させる方法ではない。
また、飲料水、産業廃液などを浄化するときに用いられ
ているポリ塩化アルミニウム、硫酸アルミニウム、アン
モニウムミョウバン、カリミョウバン、硫酸第一鉄、硫
酸第二鉄、アニオン系、ノニオン系、カチオン系の一種
よりなる高分子有機凝集剤のうちの少なくとも一種を、
処理水中に混入し、濁り物質などを沈降篩別し、上澄液
を飲料用、若しくは雑用水に供給している。篩別した濁
り物質などは、焼却若しくは殺菌後廃棄している。従っ
て、これらポリ塩化アルミニウムなどは水などを浄化す
る薬剤として、使用されているが、菌回収用の助剤とし
ては、使用されたことは本件出願人会社で調査したが、
全く発見出来なかった。2. Description of the Related Art Conventionally, as a method for recovering this kind of bacteria, a method of recovering the bacteria by centrifugal sedimentation is mainly used. However, as a method for improving the efficiency of collecting bacteria, it is only considered to increase the centrifugal force. . Increasing the centrifugal force not only increases the size of the device but also increases the cost of the equipment and reduces its usefulness. If the centrifugal force is excessively increased, the target bacteria may be killed, and increasing the centrifugal force naturally has a limit. Although electrophoresis has been used in some cases since about 1960, the technique is complicated and the apparatus itself is expensive, and this method is not a method for improving the bacterial yield.
A type of polyaluminum chloride, aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate, ferric sulfate, anionic, nonionic and cationic types used when purifying drinking water and industrial waste liquids At least one of the high molecular organic flocculants consisting of
It is mixed in the treated water, turbid substances and the like are settled and sieved, and the supernatant is supplied to drinking water or miscellaneous water. The turbid substances and the like that have been sieved are discarded after incineration or sterilization. Therefore, these polyaluminum chlorides and the like are used as agents for purifying water and the like.
I could not find it at all.
【0003】[0003]
【発明が解決しようとする課題】この発明は目的の菌を
原液乃至検体より遠心分離回収するに際し、従来水の浄
化薬剤として使用されていたポリ塩化アルミニウムなど
を用いると、遠心力が従来と同じであっても、著しく菌
の回収率が向上することを知見し、前記薬剤乃至化学品
の用途開発であり、且つこの薬剤乃至化学品を従来の遠
心分離方法に加える方法により、菌の高率な回収方法を
市場に提供することである。殊に、喀痰中より、微量の
抗酸菌を検出する方法を市場に提供する。According to the present invention, when the target bacterium is recovered by centrifugation from a stock solution or a specimen, if polyaluminum chloride or the like which has been conventionally used as a water purifying agent is used, the centrifugal force is the same as that of the prior art. However, it was found that the recovery rate of bacteria was significantly improved, and the use of the drug or chemical was developed, and the method of adding this drug or chemical to a conventional centrifugation method was used to increase the rate of bacteria. To provide the market with an efficient collection method. In particular, the present invention provides a method for detecting a trace amount of mycobacteria from sputum.
【0004】[0004]
【課題を解決するための手段】前記の課題を達成するた
めに、この物の発明はポリ塩化アルミニウムを主剤とす
る第1凝集剤、硫酸アルミニウム、アンモニウムミョウ
バン、カリミョウバン、硫酸第一鉄、硫酸第二鉄の少な
くとも一種よりなる第2凝集剤、アニオン系、ノニオン
系、カチオン系の少なくとも一種よりなる高分子有機凝
集剤のうちの少なくとも一種の凝集剤を主剤とすること
を特徴とする遠心集菌助剤とする。In order to achieve the above-mentioned object, the invention of the present invention relates to a first coagulant mainly composed of polyaluminum chloride, aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate, sulfuric acid. A centrifugal collector characterized in that at least one coagulant of at least one of a second coagulant composed of at least one of ferric iron, a high molecular organic coagulant composed of at least one of anionic, nonionic and cationic is used as a main component. Bacterial aid.
【0005】また前記の課題を達成するために、関連の
方法発明として、検体原液10ミリリットルに対しにポ
リ塩化アルミニウムを主剤とする第1凝集剤の25乃至
50%水溶液、硫酸アルミニウム、アンモニウムミョウ
バン、カリミョウバン、硫酸第一鉄、硫酸第二鉄の少な
くとも一種よりなる第2凝集剤の0.5乃至10%水溶
液、アニオン系、ノニオン系、カチオン系の少なくとも
一種よりなる高分子有機凝集剤の0.05乃至0.3%
水溶液のうち少なくとも一種の水溶液を0.01乃至
0.05ミリリットルの割合で加え、撹拌し暫時後、遠
心分離を行い、沈渣物中より目的の菌を回収する菌回収
方法とする。In order to achieve the above object, a related method invention includes a 25-50% aqueous solution of a first coagulant containing polyaluminum chloride as a main component, aluminum sulfate, ammonium alum, 0.5 to 10% aqueous solution of a second flocculant comprising at least one of potassium alum, ferrous sulfate and ferric sulfate; and 0 to 0 of a high molecular organic flocculant comprising at least one of anionic, nonionic and cationic. 0.05 to 0.3%
At least one kind of the aqueous solution is added at a ratio of 0.01 to 0.05 ml, and the mixture is stirred, and after a while, centrifuged to collect the target bacteria from the sediment.
【0006】また前記の課題を達成するために、関連の
方法発明として、検体原液を目的菌の至適pH付近に緩
衝液で調整する第1工程。第1工程処理液10ミリリッ
トルに対しにポリ塩化アルミニウムを主剤とする第1凝
集剤の25乃至50%水溶液、硫酸アルミニウム、アン
モニウムミョウバン、カリミョウバン、硫酸第一鉄、硫
酸第二鉄の少なくとも一種よりなる第2凝集剤の0.5
乃至10%水溶液、アニオン系、ノニオン系、カチオン
系の少なくとも一種よりなる高分子有機凝集剤のうちの
少なくとも一種の凝集剤の0.05乃至0.3%水溶液
のうち少なくとも一種の水溶液を0.01乃至0.05
ミリリットルの割合で加え、撹拌し暫時後、遠心分離を
行い、沈渣物中より目的の菌を回収する菌回収方法とす
る。In order to achieve the above object, as a related method invention, a first step of adjusting the stock solution of the specimen to a pH around the optimum pH of the target bacterium with a buffer solution. 25% to 50% aqueous solution of a first coagulant containing polyaluminum chloride as a main component per at least 10 ml of the treatment liquid of the first step, and at least one of aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate and ferric sulfate. 0.5 of the second flocculant
To 10% aqueous solution, and 0.05 to 0.3% aqueous solution of at least one coagulant of at least one high molecular organic coagulant comprising at least one of anionic, nonionic and cationic. 01 to 0.05
The mixture is added at a rate of milliliter, stirred, and after a while, centrifuged and centrifuged to recover the target bacteria from the sediment.
【0007】また前記の課題を達成するために、この他
の菌回収方法の前記遠心力は1300×g乃至1800
×g(半径16cm遠心分離機において2600rpm
乃至3150rpm相当)もって、約25分乃至15分
行う方法であることを特徴とすることが好ましい。また
前記の課題を達成するために、他の方法発明として、前
記菌回収法の前記検体原液は食用有用菌、薬用有用菌の
うちの少なくとも一種の菌を含むものであることを特徴
とする場合もある。In order to achieve the above object, the centrifugal force of another method for recovering bacteria has a centrifugal force of 1300 × g to 1800 × 1800.
Xg (2600 rpm in a 16 cm radius centrifuge)
(Equivalent to about 3150 rpm) for about 25 to 15 minutes. In order to achieve the above object, as another method invention, the sample stock solution of the method for collecting bacteria may be characterized in that it contains at least one kind of useful edible bacteria and medicinally useful bacteria. .
【0008】また前記の課題を達成するために、他の方
法発明として、前記菌回収法の前記検体原液は病原菌を
含む検体原液であることを特徴とする場合もある。また
前記の課題を達成するために、他の方法発明として、抗
酸菌を含むと推測される喀痰を、先ずアルカリなどの消
毒剤で、前記抗酸菌以外の菌を殺菌した均質なものとす
る第1工程。第1工程で調整後の液をpH7付近の緩衝
液で調整する第2工程。第2工程処理液10ミリリット
ルに対し、ポリ塩化アルミニウムを主剤とする第1凝集
剤の25乃至50%水溶液、硫酸アルミニウム、アンモ
ニウムミョウバン、カリミョウバン、硫酸第一鉄、硫酸
第二鉄の一種よりなる第2凝集剤の0.5乃至10%水
溶液、アニオン系、ノニオン系、カチオン系の少なくと
も一種よりなる高分子有機凝集剤の0.05乃至0.3
%水溶液の三種の水溶液のうちの少なくとも一種の水溶
液をを0.01乃至0.05ミリリットルの割合で加
え、撹拌し暫時後、1300×g乃至1800×gの遠
心力で約25分乃至15分間遠心分離し、沈渣物中より
目的の抗酸菌を回収することを特徴とする抗酸菌回収方
法とする。[0008] In order to achieve the above object, another method invention may be characterized in that the sample stock solution in the method for collecting bacteria is a sample stock solution containing pathogenic bacteria. In order to achieve the above object, as another method invention, a sputum presumed to contain acid-fast bacterium was first treated with a disinfectant such as an alkali, and then sterilized with a homogenous bacterium other than the acid-fast bacterium. The first step to be performed. The second step of adjusting the solution adjusted in the first step with a buffer solution having a pH of about 7. The second process is composed of 25 to 50% aqueous solution of the first flocculant containing polyaluminum chloride as a main component, aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate, and ferric sulfate per 10 ml of the treatment liquid in the second step. 0.5 to 10% aqueous solution of a second flocculant, 0.05 to 0.3 of a high molecular organic flocculant comprising at least one of anionic, nonionic and cationic ones
% Aqueous solution at a rate of 0.01 to 0.05 ml, and after stirring for a while, centrifugal force of 1300 × g to 1800 × g for about 25 to 15 minutes A method for recovering an acid-fast bacterium, comprising centrifuging and recovering a target acid-fast bacterium from a sediment.
【0009】前述の遠心分離機の半径は16cmに限定
されるものでなく、結果として重力の加速度として約1
300×g乃至1800×gの範囲の一つの遠心力が発
生出来る装置を用いて行う方法であればよく、一般的に
細菌分離などで普及している半径が16cmのものを用
いれば、3000rpmが好ましい。半径が16cmよ
り小さければ、回転数は3000rpmより早くなる
し、半径が16cmより大きければ、回転数は3000
rpmより遅くなり、この様な場合もこれらの発明の実
施形態に含まれる(図1のグラフ参照)。The radius of the aforementioned centrifuge is not limited to 16 cm, and as a result, the acceleration of gravity is about 1
Any method can be used as long as it is performed using a device capable of generating one centrifugal force in the range of 300 × g to 1800 × g. preferable. If the radius is smaller than 16 cm, the rotation speed will be faster than 3000 rpm, and if the radius is larger than 16 cm, the rotation speed will be 3000 rpm.
rpm, and such cases are included in the embodiments of the invention (see the graph of FIG. 1).
【0010】発明の作用 請求項1記載の特定発明は物の発明であり、一般に菌体
表面はマイナスイオンの荷電を帯びていて相互に反発
し、細かい菌が浮遊状態で安定している。従って、其の
侭遠心力集菌に使用しても、細かい菌体には充分な遠心
力が作用せず、効率良く菌を回収することが出来ない。
そこで目的の菌を含むか、その他の菌が含まれているか
否かの検体液より遠心力集菌をするに先立ち、目的の検
体原液中に前記凝集剤を所定割合で含む前記三種の水溶
液のうちの少なくとも一種の前記水溶液を添加すると、
これはプラスの電荷のため前記菌の表面電位を中和す
る。よって、菌体は相互に接近し易い状態となり、菌同
士、及び他の夾雑物は相互に凝集し、凝集塊を形成す
る。この状態において、遠心力を加えれば、凝集塊に対
して有効に作用し、沈殿分離し、この沈殿物中に集菌さ
れる確率は格段に向上する。Action of the Invention The specific invention described in claim 1 is an invention of a product. Generally, the surface of a cell is charged with negative ions and repels each other, and fine bacteria are stable in a floating state. Therefore, even if it is used for centrifugal force collection as it is, sufficient centrifugal force does not act on fine cells, and it is not possible to efficiently collect bacteria.
Therefore, containing the target bacteria, prior to collecting the centrifugal force from the sample liquid whether or not other bacteria are contained, the three aqueous solutions containing the flocculant at a predetermined ratio in the target sample stock solution When at least one of the aqueous solutions is added,
This neutralizes the surface potential of the bacterium due to the positive charge. Thus, the cells are in a state where they can easily approach each other, and the bacteria and other contaminants are mutually aggregated to form an aggregate. In this state, if a centrifugal force is applied, it effectively acts on the aggregates, precipitates and separates, and the probability of cells being collected in the precipitates is significantly improved.
【0011】請求項2記載の発明に於いては、先ず、検
体原液が粘稠性の無い場合は其の侭の液に、前記三種の
凝集剤の水溶液のうちの少なくとも一種の水溶液を添加
すし、充分に混合し、各菌体表面電位を満遍なく中和
し、より大きな凝集塊を形成する。前記の各水溶液の混
合比は前記の範囲より少なくても、各菌体表面電位の充
分な中和作用は得られないし、多過ぎても逆にプラスの
荷電となり、再び凝集が起こらなくなる。この様な状態
で、従来と同程度遠心力を加えると、凝集している菌及
び他の夾雑物は簡単に遠心沈殿する。In the invention of claim 2, first, when the sample stock solution is not viscous, at least one aqueous solution among the three aqueous solutions of the aggregating agent is added to the undiluted solution. Mix thoroughly to neutralize each cell surface potential evenly and form larger aggregates. If the mixing ratio of each aqueous solution is less than the above range, a sufficient neutralizing effect on the surface potential of each bacterial cell cannot be obtained, and if it is too large, it will be positively charged and aggregation will not occur again. In such a state, when a centrifugal force is applied to the same degree as in the related art, the aggregated bacteria and other contaminants are easily precipitated by centrifugation.
【0012】請求項3記載の発明に於いては、検体原液
が粘稠性の大きいとき、或は培地から採取された場合な
ど、何らかの処理が施されている場合は、先ず緩衝液、
若しくは稀釈液で検体原液を目的菌の至適pH付近に調
整すると、検体原液の粘稠度を低下し、撹拌性及び流動
性が向上し、目的菌の生存率を高め、第2工程で加える
前記三種の水溶液のうちの少なくとも一種の水溶液が充
分に混合し、各菌体表面電位を満遍なく中和し、より大
きな凝集塊を形成する作用をなす。According to the third aspect of the present invention, when the sample stock solution is highly viscous or when some processing is performed, such as when it is collected from a culture medium, the buffer solution,
Alternatively, if the sample stock solution is adjusted to a pH around the target bacterium with a diluent, the viscosity of the sample stock solution is reduced, stirring and fluidity are improved, the survival rate of the target bacterium is increased, and the sample is added in the second step. At least one of the three aqueous solutions is sufficiently mixed to neutralize the surface potential of each bacterial cell evenly, and has the effect of forming a larger aggregate.
【0013】請求項4記載の発明に於いては、遠心力お
よび、その作動時間が前述の範囲であるから、遠心分離
器として通常細菌分離などに汎用されている装置が其の
侭使用出来、分離中の目的の菌体を破壊する程高速回転
ではないし、作動時間も短く能率がよい作用をなす。従
って、この沈渣物には高率の菌が回収される作用をな
す。According to the fourth aspect of the present invention, since the centrifugal force and the operation time are within the above-mentioned ranges, an apparatus generally used as a centrifuge for separating bacteria or the like can be used as it is. The rotation speed is not high enough to destroy the target cells during the separation, and the operation time is short and the operation is efficient. Therefore, the sediment serves to recover a high percentage of bacteria.
【0014】請求項5記載の発明においては、前記請求
項2、3又は4記載の発明の作用のほか、食品有用菌、
薬品有用菌の回収に高率よく集菌できる作用をなす。請
求項6記載の発明においては、前記請求項2、3又は4
記載の発明の作用のほか、特定されていない病原菌を検
出するとき、集菌効率が高いから少ない検体から、若し
くは菌数が微量の検体からでも、菌を発見出来る率が向
上する作用をなす。According to the fifth aspect of the present invention, in addition to the effects of the second, third or fourth aspect of the present invention, useful food bacteria,
It has the function of collecting bacteria useful for medicine at a high rate. In the invention according to claim 6, the second, third or fourth aspect of the present invention is provided.
In addition to the effects of the described invention, when detecting an unspecified pathogenic bacterium, it has an effect of increasing the rate at which the bacterium can be detected from a small sample because of its high collection efficiency or even from a sample with a very small number of bacteria.
【0015】請求項7記載の発明においては、請求項2
又は3記載の発明の作用のほか抗酸菌を含むと推測され
る喀痰を検体原液とし、先ずアルカリなどの消毒剤で、
前記抗酸菌以外の菌を殺菌した均質なものとするから、
抗酸菌のみが集菌の対象となり、更にpH7付近の緩衝
液で稀釈するから、検体原液の粘稠度が低下し、凝集が
起こりやすい作用をなす。また抗酸菌を含む場合にその
生存率を殆ど低下させない作用をなす。その他の作用は
請求項2及び3記載の発明の作用同様であり、最終的に
抗酸菌が効率良く回収され、或は微量の抗酸菌を含む検
体原液からでも、抗酸菌の発見が可能となる作用をな
す。In the invention according to claim 7, claim 2 is provided.
Or the sputum presumed to contain the acid-fast bacterium in addition to the action of the invention according to 3 as a sample stock solution, first with a disinfectant such as alkali,
Because the bacteria other than the acid-fast bacterium are sterilized and homogeneous,
Only the acid-fast bacterium is to be collected and further diluted with a buffer solution having a pH of about 7, so that the consistency of the sample stock solution is reduced and aggregation is likely to occur. Also, when it contains an acid-fast bacterium, it has an effect of hardly lowering the survival rate. Other actions are the same as the actions of the inventions of claims 2 and 3, and the acid-fast bacterium is efficiently recovered in the end, or the acid-fast bacterium can be discovered even from a sample stock solution containing a trace amount of the acid-fast bacterium. Performs a possible function.
【0016】実施の形態1 請求項1記載の発明の助剤を用いた請求項2、3、4及
び5記載の発明の実施の形態であり、菌体としては食用
有用菌の一種を含む培養後の液体培地を、緩衝液で目的
菌の至適pH例えばpH7に調整し、これに処理液10
ミリリットルに対しに第1凝集剤たるポリ塩化アルミニ
ウムの25乃至50%水溶液を0.01乃至0.05ミ
リリットルの割合で加え、撹拌し暫時後、1300×g
乃至1800×gで25分乃至15分遠心沈殿を行う。
第1凝集剤の25乃至50%水溶液の代わりに、第2凝
集剤の0.5乃至10%水溶液若しくは、高分子有機凝
集剤のうちの少なくとも一種の凝集剤の0.05乃至
0.3%水溶液を用いる場合もある。而して沈渣物よ
り、目的の菌を回収する。緩衝液としてはリン酸緩衝液
に限定されないし、回収する菌の種類によっては予め、
緩衝液のpHが目的菌の至適pHと対応する緩衝液を用
いる。Embodiment 1 This is an embodiment of the invention as set forth in claims 2, 3, 4 and 5 using the auxiliary of the invention as set forth in claim 1, wherein the cells contain a kind of useful edible bacteria. The subsequent liquid medium was adjusted to the optimum pH of the target bacterium, for example, pH 7, with a buffer solution.
A 25 to 50% aqueous solution of polyaluminum chloride as a first coagulant is added to the milliliter in an amount of 0.01 to 0.05 milliliter, and after stirring for a while, 1300 × g
Centrifuge at 1800 × g for 25 to 15 minutes.
Instead of the 25 to 50% aqueous solution of the first flocculant, a 0.5 to 10% aqueous solution of the second flocculant or 0.05 to 0.3% of at least one flocculant among the high molecular organic flocculants An aqueous solution may be used. Thus, the target bacteria are recovered from the sediment. The buffer is not limited to a phosphate buffer, and depending on the type of bacteria to be recovered,
Use a buffer in which the pH of the buffer corresponds to the optimal pH of the target bacterium.
【0017】実施の形態2 請求項1記載の発明の助剤を用いた請求項2記載の方法
発明の実施の形態である。検体原液が比較的大量に得ら
れ、粘稠性の低い液体の場合、例えば患者の尿の場合、
其の侭を検体原液とし、これの検体原液前記10ミリリ
ットルに対し、実施の形態1と同様に、前記凝集剤を含
む水溶液を、前記の割合で加え、撹拌し暫時後、遠心管
として15ミリリットル乃至50ミリリットルのものを
用い、前記遠心力は1300×g乃至1800×gで2
5分乃至15分遠心沈殿を行う。而して沈渣物中より、
目的の菌を回収する。若しくはこの沈渣物を培養源と
し、培地に移植する。Embodiment 2 This is an embodiment of the method invention according to claim 2 using the assistant of the invention described in claim 1. When a relatively large amount of the sample stock solution is obtained and the liquid is less viscous, for example, in the case of patient urine,
As it is, as a sample stock solution, an aqueous solution containing the aggregating agent was added to the sample stock solution (10 ml) in the same manner as in Embodiment 1 at the ratio described above, and stirred, and after a while, 15 ml as a centrifuge tube And a centrifugal force of 1300 × g to 1800 × g.
Centrifuge for 5 to 15 minutes. Thus, from the sediment,
Collect the desired bacteria. Alternatively, the sediment is used as a culture source and transplanted into a medium.
【0018】実施の形態3 請求項1記載の発明の助剤を用いた請求項3、4及び5
記載の発明の実施の形態であり、菌体としては薬用若し
くは食用有用菌の一種を含む培養後の液体培地を、緩衝
液で稀釈して、目的菌の至適pHに調整し、これに処理
液10ミリリットルに対し、実施の形態1と同様に、前
記凝集剤を含む水溶液を、前記の割合で加え、撹拌し暫
時後、実施の形態1と同一の条件で遠心集菌する。Embodiment 3 Claims 3, 4 and 5 using the auxiliary of the invention described in claim 1.
It is an embodiment of the invention described, wherein the liquid medium after culturing containing one kind of medicinal or edible useful bacteria is diluted with a buffer solution, adjusted to the optimal pH of the target bacteria, and treated. An aqueous solution containing the aggregating agent is added to 10 ml of the liquid in the same ratio as in the first embodiment, and the mixture is stirred. After a while, the cells are centrifuged under the same conditions as in the first embodiment.
【0019】実施の形態4 請求項6記載の発明を含む実施の形態であり、未知の病
原菌を含む検体原液、例えば患者の排泄物、或いは食品
残滓の溶液を緩衝液で集菌目的菌の発育至適pH、例え
ばpH7、pH5.6若しくはpH8.0若しくはこれ
以上のランク分けられた対応するそれぞれpHの異なる
緩衝液を用いて、それぞれのpHに前記検体原液を調整
し、その後、実施の形態1と同様の前記凝集剤を含む水
溶液を前記の割合でそれぞれに混合し、実施の形態1と
同一の条件でそれぞれ遠心集菌する。遠心集菌後、これ
を培養源として更に培養し、菌の特定を行う。Embodiment 4 This is an embodiment including the invention according to claim 6, wherein a stock solution containing unknown pathogenic bacteria, for example, a solution of patient excrement or food residue is collected with a buffer solution to grow bacteria to be collected. The sample stock solution is adjusted to the respective pH using a buffer having an optimum pH, for example, pH 7, pH 5.6, or pH 8.0 or higher, and corresponding pHs are different. The same aqueous solution containing the aggregating agent as in Example 1 is mixed with each of the above-described ratios, and the cells are collected by centrifugation under the same conditions as in Embodiment 1. After centrifugation, this is further cultured using this as a culture source to identify the bacteria.
【0020】実施の形態5 請求項7記載の発明を含む実施の形態であり、抗酸菌特
に結核菌を含むと推測される喀痰を検体原液とし、先ず
アルカリなどの消毒剤で、前記抗酸菌以外の菌を殺菌
し、均質なものとする第1工程。第1工程で調整後の液
をpH7付近の緩衝液で稀釈調整する。これによって、
アルカリなどの消毒剤によるアルカリ性を是正する第2
工程。第2工程処理液10ミリリットルに対し、実施の
形態1と同様の前記凝集剤を含む水溶液を前記の割合で
それぞれに混合し、実施の形態1と同一の条件でそれぞ
れ遠心分離を行い、沈渣物中より目的の抗酸菌を回収す
る。或は前記沈渣物を培養源として、更に液体培地で所
定期間培養し、再度同様の方法を繰返し、抗酸菌特に結
核菌の回収を行う。Embodiment 5 An embodiment including the invention according to claim 7, wherein sputum which is presumed to contain acid-fast bacilli, especially tuberculosis bacterium, is used as a sample stock solution, and the anti-acid bacterium is firstly treated with a disinfectant such as an alkali. A first step in which bacteria other than bacteria are sterilized and made uniform. The solution adjusted in the first step is diluted and adjusted with a buffer solution having a pH of about 7. by this,
The second to correct alkalinity by disinfectants such as alkali
Process. The same aqueous solution containing the flocculant as in the first embodiment was mixed with the above-mentioned ratio in 10 ml of the treatment liquid in the second step at the above-mentioned ratio, and each was centrifuged under the same conditions as in the first embodiment to obtain a sediment. The target acid-fast bacterium is recovered from the inside. Alternatively, the sediment is used as a culture source, and further cultured in a liquid medium for a predetermined period of time, and the same method is repeated again to collect mycobacteria, particularly tuberculosis bacteria.
【0021】本件発明に用いられる緩衝液としては、リ
ン酸緩衝液(スレンセンのリン酸緩衝液を含む)を用
い、目的に応じ予めpHを定めて用意する。また、稀釈
液としては生理的食塩水又は精製水を用いる。As the buffer used in the present invention, a phosphate buffer (including Slensen's phosphate buffer) is used, and the pH is previously determined and prepared according to the purpose. Physiological saline or purified water is used as the diluting solution.
【0022】実験例 実験菌 東京BCG菌株 喀痰モデルとしてペプトン4%、ムチン1%の水溶液を
用い、これに前記菌10ー 4ミリグラム/ミリリットル入
れ、これを検体とした。遠心管3本にそれぞれ検体1ミ
リリットルとM/15リン酸緩衝液9ミリリットルを加
え、1本は其の侭、他の1本には集菌助剤として前記ポ
リ塩化アルミニウムの40%水溶液を0.04ミリリッ
トルを添加し、撹拌後半径16cmの遠心力分離器を用
い、それぞれ3000rpm(重力の加速度で示せば約
1600×g)の回転で約20分間回転し、遠心力分離
し、各上澄液を0.1ミリリットルを1%小川培地に各
5本接種培養し、上澄液に残存する菌数を計測した。ま
た沈渣菌数を測定した。結果は表1に示す通りである。[0022] peptone 4% as an experimental example Experimental bacteria Tokyo BCG strains sputum model, using a 1% aqueous solution mucin, which put the bacteria 10 -4 mg / ml, which was used as a specimen. One milliliter of the sample and 9 milliliters of M / 15 phosphate buffer were added to each of three centrifuge tubes. One of the centrifuge tubes was left as it was, and the other was mixed with the 40% aqueous solution of polyaluminum chloride as an adjuvant. After stirring, centrifugal separation was performed using a centrifugal separator with a radius of 16 cm at a rotation of 3000 rpm (approximately 1600 × g as indicated by the acceleration of gravity) for 20 minutes, and centrifugal separation was performed. Five milliliters of the solution were inoculated and cultured in 1% Ogawa's medium for 5 cells each, and the number of bacteria remaining in the supernatant was counted. The number of bacteria in the sediment was measured. The results are as shown in Table 1.
【0023】[0023]
【表1】 上澄菌数 沈渣菌数 合計菌数 菌回収率 3000rpm 864 1,372 2,236 61.4% 300rpm+助剤 126 2,288 2,414 94.8% 3,000×g 567 1,796 2,372 75.7Table 1 Number of supernatant bacteria Number of sediment bacteria Total number of bacteria Bacterial recovery 3000 rpm 864 1,372 2,236 61.4% 300 rpm + auxiliary 126 2,288 2,414 94.8% 3,000 xg 567 1,796 2,372 75.7
【0024】前記の表1からも判るように、単に300
0rpmの遠心では61.4%の回収に過ぎないもの
が、本件発明の請求項1記載の発明の助剤を前述の範囲
で加えることによって、同一遠心力と作動時間で94.
8%とと云う驚異的な菌回収率を得、従来の3,000
×g(4,100rpm相当)の遠心力による75.7
%をも遥かに凌ぐ高回収率を得た。As can be seen from Table 1, only 300
By centrifugation at 0 rpm, only 61.4% of the solution was recovered. However, by adding the auxiliary agent according to the first aspect of the present invention within the above-mentioned range, the same centrifugal force and operation time were obtained.
A tremendous bacterial recovery rate of 8% was obtained, and the
75.7 centrifugal force of × g (equivalent to 4,100 rpm)
%, Which is much higher than the above.
【0025】[0025]
【発明の効果】請求項1記載の物の発明に於いては、前
述の各凝集剤は前述の通り、遠心分離に先立ちこれを、
検体調整液に加えることによって、菌体の荷電を中和
し、相互の反発がなくなり、菌体同士が凝集し易くな
り、大きな菌集落となり、より遠心力が作用する効果を
発揮する。従って菌回収率を向上させる効果を奏する。According to the invention of the first aspect, each of the above-mentioned flocculants is used as described above before centrifugation.
When added to the sample preparation solution, the charge of the cells is neutralized, mutual repulsion is eliminated, the cells are easily aggregated, the cells become large colonies, and a centrifugal force is exerted. Therefore, the effect of improving the bacterial recovery is exhibited.
【0026】請求項2記載の方法発明に於いては、検体
原液が比較的大量にあり、粘稠度の高い場合に適し、極
僅かの病原菌をも発見できる効果を有する。請求項3記
載の方法発明に於いては、予め、緩衝液、稀釈液でpH
を調整してから前記の凝集剤がそれぞれ所定割合で添加
された水溶液を遠心分離前に添加撹拌する方法であるか
ら、この混合は容易であり、且つ菌体の凝集も容易であ
り、前述の通り目的の菌を高回収率で回収でき、且つ遠
心回転数も、比較的低回転数でよく、菌体を破壊するお
それも少ない。請求項4記載の遠心力であれば、一般に
普及している遠心分離器が使用出来、且つ、菌体を破壊
するおそれもなく、作動時間も余り長くなく作業性がよ
く、菌回収効率が殊の外よい。According to the second aspect of the present invention, the method is suitable for the case where the sample stock solution is relatively large in volume and the consistency is high, and has an effect that even a very small amount of pathogenic bacteria can be found. In the method according to the third aspect of the present invention, the pH and the buffer solution and the diluting solution are adjusted in advance.
This method is a method of adding and stirring the aqueous solution to which the coagulant is added at a predetermined ratio before centrifugation, and therefore, the mixing is easy, and the flocculation of the cells is also easy. As described above, the target bacterium can be recovered at a high recovery rate, the centrifugal rotation speed can be relatively low, and there is little possibility that the cells are destroyed. In the case of the centrifugal force described in claim 4, a widely used centrifugal separator can be used, there is no possibility of destroying the cells, the operation time is not too long, the workability is good, and the efficiency of collecting bacteria is particularly high. Good outside.
【0027】請求項5記載の方法発明に於いては、検体
として、食品有用菌、薬有用菌の分離に、前記の方法を
用いるものであるから、これらの菌回収率が向上し、食
品有用菌、薬有用菌の生産効率が向上する効果を奏す
る。請求項6記載の方法発明に於いては、検体として、
何らかの病原菌を含むであろう患者の排泄物乃至その他
の体液、保存食品、食品残滓などのを用い、前記の助剤
を用いた後に遠心分離し、これを培養源とすればより高
濃度の培養源となり、病原菌の発見を容易にする効果を
奏する。In the method according to the fifth aspect of the present invention, since the above-mentioned method is used for separating useful food bacteria and medicinal useful bacteria as specimens, the recovery rate of these bacteria is improved, and This has the effect of improving the production efficiency of bacteria and medicinal useful bacteria. In the method invention according to claim 6, as the specimen,
Using excretions or other body fluids of patients who may contain some pathogenic bacteria, preserved foods, food residues, etc., centrifugation after using the above-mentioned auxiliary, and using this as a culture source, a higher concentration culture It has the effect of facilitating the discovery of pathogenic bacteria.
【0028】請求項7記載の方法発明に於いては、検体
として、抗酸菌主として結核菌を含むと推測される患者
の喀痰を先ずアルカリ性の消毒剤で消毒する工程によ
り、抗酸菌以外の菌は死滅し、次いで、リン酸緩衝液で
再び中性付近に戻すから、以後の方法中に、抗酸菌が死
滅乃至が衰えることも少なく、以後他の方法発明の方法
と同様の方法を行うから、抗酸菌が含まれておれば、こ
れが高回収率で回収されるため、従来疑陽性とされたも
のも、明確に検出可能となり、以後の治療乃至隔離が迅
速にでき、患者本人にとっても回復を早め、社会的にも
蔓延率を低下させ福音である。In the method according to the present invention, the sputum of a patient presumed to contain mainly acid-fast bacilli as a specimen is first disinfected with an alkaline disinfectant, thereby obtaining a sample other than acid-fast bacilli. Since the bacteria are killed and then returned to near neutrality again with the phosphate buffer, the acid-fast bacteria are rarely killed or diminished during the subsequent method. Therefore, if acid-fast bacterium is contained, it is recovered at a high recovery rate, so that what was conventionally false positive can be clearly detected, and subsequent treatment or isolation can be performed quickly, and the patient himself It is a gospel that hastened recovery and reduced the prevalence of the disease socially.
【0029】前記請求項2乃至7記載の発明において、
前記助剤であるポリ塩化アルミニウムの添加量も前述の
範囲であれば菌体の凝集効果が充分に得られ、この範囲
を上下に超えると、菌体の凝集効果が得られにくい場合
もある。[0029] In the invention according to claims 2 to 7,
If the amount of the polyaluminum chloride as the auxiliary agent is also in the above-mentioned range, a sufficient effect of aggregating cells can be obtained. If the amount exceeds this range, the effect of aggregating cells may be hardly obtained.
【0030】実施例 1.発酵による有用食品例 実施例1 乳酸菌の場合 雑菌のない正常清潔な培地で培養された乳酸菌は一般に
乳酸菌自体から産生される乳酸により、相当酸性であ
り、先ずリン酸産緩衝液でpH7に調整する。この処理
液を前記のポリ塩化アルミニウムを含む第1凝集剤の前
記の割合としてある水溶液を前記の割合で加え、撹拌
後、1600×gで20分間遠心分離し、その沈渣中よ
り乳酸菌を回収する。有用食品菌としては、前記の他、
各種酵母菌、イ−スト菌などの回収に活用し得る。Embodiment 1 Examples of useful foods by fermentation Example 1 In the case of lactic acid bacteria Lactic acid bacteria cultured in a normal and clean medium without germs are generally considerably acidic due to lactic acid produced by the lactic acid bacteria itself, and first adjusted to pH 7 with a phosphate buffer. . This treatment solution is added to the above-mentioned aqueous solution of the first flocculant containing polyaluminum chloride at the above-mentioned ratio, and after stirring, the mixture is centrifuged at 1600 × g for 20 minutes, and lactic acid bacteria are recovered from the sediment. . As useful food bacteria, other than the above,
It can be used for recovery of various yeasts and yeasts.
【0031】2.培養による有用薬品例 実施例2 ストレプトマイセス・リモサスの場合 清浄な液体培地において、ストレプトマイセス・リモサ
スを培養したものを原液とし、リン酸緩衝液でpH7に
調整し、以下実施例1と同様の方法を実施し、目的の菌
を沈渣物中より回収した。前記例示の菌のほか、ペネシ
リウム菌などの他の抗生物質産生菌の回収にも同様に行
える。2. Examples of useful chemicals by culturing Example 2 In the case of Streptomyces limosas In a clean liquid medium, a culture of Streptomyces limosas was used as a stock solution, adjusted to pH 7 with a phosphate buffer, and then similar to Example 1 The target bacteria were recovered from the sediment. In addition to the above-mentioned bacteria, other antibiotic-producing bacteria such as Penesillium can be similarly collected.
【0032】3.病原菌検出の例 実施例3 肺炎球菌の場合 患者喀痰を緩衝液のpHが肺炎球菌の至適pHに含まれ
るpHの緩衝液を用い、この緩衝液を加え、肺炎球菌の
至適pHたるpH8.1乃至8.3に調整し、後は実施
例1の方法と同様の方法を実施し、沈渣物中より、肺炎
球菌を回収する。或いはこの沈渣物をされに清浄な培地
に移植し、再度同様の方法を繰返し、肺炎球菌を回収す
る。 実施例4 百日咳菌の場合 患者喀痰を百日咳に至適pHpHの緩衝液を用い、pH
4.3乃至5.6に前記実施例3と同様にリン酸緩衝液
で調整する。必要に応じ、pH調整剤で前記の範囲に調
整する方法もこの発明に含まれる。その後実施例1と同
様の方法を実施する。前記実施例3、4の他、ブドウ球
菌などのグラム陽性球菌、ジフテリヤなどのグラム陽性
悍菌、前記百日咳以外の病原性腸内細菌などのグラム陰
性悍菌などの検出に最適である。3. Example 3 Detection of Pathogenic Bacteria Example 3 In the case of pneumococcus A patient's sputum was used as a buffer having a pH contained in the optimal pH of pneumococcus. After adjusting to 1 to 8.3, the same method as in Example 1 is performed, and pneumococcus is recovered from the sediment. Alternatively, the sediment is transplanted to a clean medium, and the same method is repeated again to collect pneumococci. Example 4 In the case of B. pertussis A patient's sputum was subjected to
Adjust to 4.3 to 5.6 with phosphate buffer as in Example 3. If necessary, the present invention also includes a method of adjusting the pH to the above range with a pH adjuster. After that, the same method as in the first embodiment is performed. In addition to Examples 3 and 4, it is most suitable for detecting Gram-positive cocci such as staphylococci, Gram-positive bacteria such as diphtheria, and Gram-negative bacteria such as pathogenic intestinal bacteria other than pertussis.
【0033】実施例5 食中毒など未だ病原菌が特定されていない場合 食品の残滓、保存食の一部、患者の排泄物の一部、患者
から採取した体液の一種を検体原液とし、これにpH7
の緩衝液を用いて、pH7付近に調整する。或は、予
め、pH6、pH7、pH8.3の緩衝液を用意し、こ
れらによって前記の検体原液をpH7中心としたpH6
乃至8、pH4.3乃至6、pH8乃至8.5の3組に
それぞれ調整する。而して、それぞれの処理液に実施例
1と同様にポリ塩化アルミニウムを加え、遠心沈殿し
て、それぞれの沈渣物を別々に培養する。更に各培養さ
れ、培地に形成された集落毎に、別々に採取して、これ
らを前回同様に緩衝液で調整し、ポリ塩化アルミニウム
を加え、遠心沈殿して、沈渣物中の菌を顕微鏡で検査し
て病原菌を検出し食中毒菌を特定する。 実施例6 検体原液が尿の場合 尿の場合は比較的検体源液が多く、かつ粘稠性も小さい
ため、特に稀釈乃至緩衝液を加えること無く、直ちにポ
リ塩化アルミニウムの水溶液を加え、遠心沈殿して、沈
渣物中より、性病の梅毒菌、淋菌や泌尿器系疾患の病原
菌を検出するExample 5 In the case where pathogenic bacteria such as food poisoning have not yet been identified, a residue of food, a part of preserved food, a part of excretion of a patient, and a kind of body fluid collected from the patient are used as a sample stock solution,
PH is adjusted to around 7 using the above buffer solution. Alternatively, buffer solutions of pH 6, pH 7, and pH 8.3 are prepared in advance, and these are used to adjust the pH of the sample stock solution to pH 6 centered on pH 7.
To 8, pH 4.3 to 6, and pH 8 to 8.5. Thus, polyaluminum chloride is added to each of the treatment solutions in the same manner as in Example 1, and the precipitates are centrifuged and the respective sediments are separately cultured. Furthermore, each cultivation was separately collected for each colony formed in the medium, and these were adjusted with a buffer solution in the same manner as the previous time, polyaluminum chloride was added, centrifuged, and the bacteria in the sediment were examined with a microscope. Inspect to detect pathogenic bacteria and identify food poisoning bacteria. Example 6 When the sample stock solution is urine In the case of urine, since the sample source solution is relatively large and the viscosity is small, immediately add an aqueous solution of polyaluminum chloride without diluting or adding a buffer solution, and centrifuge. To detect syphilis, gonococci and pathogens of urinary diseases in the sediment
【0034】実施例7 抗酸菌特に結核菌の場合 他の検査で結核感染者と判定された患者の喀痰を2%の
苛性ソ−ダである消毒剤で消毒して、他の雑菌乃至病原
菌を殺菌する。一旦アルカリ性になった検体を次いでリ
ン酸緩衝液でpH7付近に調整する。結核菌は至適pH
が5.0乃至8.4であるから、結核菌を生存させて置
くためにである。以後実施例1と同様にポリ塩化アルミ
ニウムの水溶液を加え、遠心沈殿して、沈渣物中に結核
菌が存在すれば、結核発病者であることが患者として確
定できる。場合によっては、前記沈渣物を培養し、培養
物に前記のポリ塩化アルミニウムを加え、遠心沈殿し
て、再度沈渣物中に結核菌が存在するか否かを検査すれ
ば、検査精度は格段に向上する。Example 7 Mycobacteria, especially Mycobacterium tuberculosis The sputum of a patient determined to be infected with tuberculosis by another test is disinfected with a 2% caustic soda disinfectant to produce other bacteria or pathogenic bacteria. Sterilize. The sample, which has become alkaline once, is then adjusted to around pH 7 with a phosphate buffer. Mycobacterium tuberculosis has an optimal pH
Is from 5.0 to 8.4, so that M. tuberculosis can be kept alive. Thereafter, in the same manner as in Example 1, an aqueous solution of polyaluminum chloride is added, and the mixture is centrifuged and precipitated. In some cases, the sediment is cultured, the above-mentioned polyaluminum chloride is added to the culture, and the mixture is centrifuged and sedimented again to examine whether M. tuberculosis is present in the sediment. improves.
【0035】各実施例において、ポリ塩化アルミニウム
の40%水溶液の代わりに、ポリ塩化アルミニウムの2
5乃至50%水溶液を用いても、同様の効果が得られる
し、硫酸アルミニウム、アンモニウムミョウバン、カリ
ミョウバン、硫酸第一鉄、硫酸第二鉄の少なくとも一種
よりなる第2凝集剤の0.5乃至10%水溶液、アニオ
ン系、ノニオン系、カチオン系の一種よりなる高分子有
機凝集剤のうちの少なくとも一種の凝集剤の0.05乃
至0.3%水溶液のうち少なくとも一種の水溶液を用い
ても、概ね同様の結果が得られる。また、第1凝集剤の
水溶液と高分子有機凝集剤のうちの少なくとも一種の凝
集剤の混合水溶液、第2凝集剤の水溶液と高分子有機凝
集剤のうちの少なくとも一種の凝集剤の混合水溶液を用
いても、略同様の結果が得られる。In each of the examples, instead of a 40% aqueous solution of polyaluminum chloride, 2% of polyaluminum chloride was used.
The same effect can be obtained by using a 5 to 50% aqueous solution, and 0.5 to 50% of a second coagulant comprising at least one of aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate and ferric sulfate. 10% aqueous solution, at least one aqueous solution of 0.05 to 0.3% aqueous solution of at least one coagulant of high molecular organic coagulant of one kind of anionic, nonionic and cationic, Generally similar results are obtained. Further, a mixed aqueous solution of an aqueous solution of the first flocculant and at least one coagulant of the high molecular organic coagulant, and a mixed aqueous solution of the aqueous solution of the second coagulant and at least one coagulant of the high molecular organic coagulant are used. When used, substantially the same results are obtained.
【図1】図は遠心力算出モノグラフである。FIG. 1 is a centrifugal force calculation monograph.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B063 QA01 QA19 QQ03 QQ05 QQ06 QQ07 QQ16 QQ20 QR41 QR50 QR51 QS11 QS13 QS20 4B065 AA01X AA36X AA38X AA50X AA57X AA67X AA72X BD15 BD22 BD25 BD50 CA42 CA46 CA60 4D015 BA03 BA04 BA05 BA11 BA21 BA22 BB06 CA20 DA04 DA05 DA06 DA15 DA16 DB01 DC02 DC06 DC07 DC08 EA04 EA13 EA14 EA15 EA16 EA22 EA39 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4B063 QA01 QA19 QQ03 QQ05 QQ06 QQ07 QQ16 QQ20 QR41 QR50 QR51 QS11 QS13 QS20 4B065 AA01X AA36X AA38X AA50X AA57X AA67X AA72X BD15 BD22 BD25 BA04 BA05 BA22 CA20 DA04 DA05 DA06 DA15 DA16 DB01 DC02 DC06 DC07 DC08 EA04 EA13 EA14 EA15 EA16 EA22 EA39
Claims (7)
集剤、硫酸アルミニウム、アンモニウムミョウバン、カ
リミョウバン、硫酸第一鉄、硫酸第二鉄の少なくとも一
種よりなる第2凝集剤、アニオン系、ノニオン系、カチ
オン系の一種よりなる高分子有機凝集剤のうちの少なく
とも一種の凝集剤を主剤とすることを特徴とする遠心集
菌助剤。1. A first coagulant comprising polyaluminum chloride as a main component, a second coagulant comprising at least one of aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate and ferric sulfate, anionic and nonionic A centrifugal bacteria collection assistant characterized in that at least one kind of cationic organic polymer flocculant is used as a main agent.
アルミニウムを主剤とする第1凝集剤の25乃至50%
水溶液、硫酸アルミニウム、アンモニウムミョウバン、
カリミョウバン、硫酸第一鉄、硫酸第二鉄の少なくとも
一種よりなる第2凝集剤の0.5乃至10%水溶液、ア
ニオン系、ノニオン系、カチオン系の少なくとも一種よ
りなる高分子有機凝集剤の0.05乃至0.3%水溶液
のうち少なくとも一種の水溶液を0.01乃至0.05
ミリリットルの割合で加え、撹拌し暫時後、遠心分離を
行い、沈渣物中より目的の菌を回収する菌回収方法。2. 25 to 50% of a first flocculant containing polyaluminum chloride as a main component per 10 ml of a sample stock solution
Aqueous solution, aluminum sulfate, ammonium alum,
0.5 to 10% aqueous solution of a second flocculant comprising at least one of potassium alum, ferrous sulfate and ferric sulfate; and 0 to 0 of a high molecular organic flocculant comprising at least one of anionic, nonionic and cationic. Of at least one aqueous solution of 0.01 to 0.05%
A method of collecting bacteria at a rate of milliliters, stirring the mixture for a while, and then centrifuging to collect the desired bacteria from the sediment.
液、稀釈液の少なくとも一種で調整する第1工程。第1
工程処理液10ミリリットルに対しにポリ塩化アルミニ
ウムの第1凝集剤の25乃至50%水溶液、硫酸アルミ
ニウム、アンモニウムミョウバン、カリミョウバン、硫
酸第一鉄、硫酸第二鉄の一種よりなる第2凝集剤の0.
5乃至10%水溶液、アニオン系、ノニオン系、カチオ
ン系の少なくとも一種よりなる高分子有機凝集剤の0.
05乃至0.3%水溶液の三種の水溶液のうちの少なく
とも一種の水溶液を0.01乃至0.05ミリリットル
の割合で加え、撹拌し暫時後、遠心分離を行い、沈渣物
中より目的の菌を回収する菌回収方法。3. A first step in which a sample stock solution is adjusted to at least an optimum pH of a target bacterium with at least one of a buffer solution and a diluting solution. First
25 to 50% aqueous solution of the first coagulant of polyaluminum chloride per 10 ml of the processing solution, and the second coagulant comprising one of aluminum sulfate, ammonium alum, potassium alum, ferrous sulfate and ferric sulfate 0.
A 5 to 10% aqueous solution, a high-molecular organic coagulant comprising at least one of anionic, nonionic and cationic types.
At least one aqueous solution of the three aqueous solutions of 0.05 to 0.3% aqueous solution was added at a ratio of 0.01 to 0.05 ml, and the mixture was stirred and centrifuged for a while. Bacterial recovery method to be recovered.
1800×g(半径16cm遠心分離機において260
0rpm乃至3150rpm相当)もって、約25分乃
至15分行う方法であることを特徴とする請求項2又は
3記載の菌回収方法。4. The centrifugal force of the centrifugation is 1300 × g to 1800 × g (260 centimeters in a 16 cm radius centrifuge).
The method according to claim 2 or 3, wherein the method is carried out for about 25 to 15 minutes (equivalent to 0 to 3150 rpm).
うちの少なくとも一種の菌を含むものであることを特徴
とする請求項2、3又は4記載の菌回収方法。5. The method according to claim 2, wherein the sample stock solution contains at least one kind of useful edible bacteria and useful medicinal bacteria.
とを特徴とする請求項2、3又は4記載の菌回収方法。6. The method according to claim 2, wherein the specimen is a specimen stock solution containing pathogenic bacteria.
とし、先ずアルカリなどの消毒剤で、前記抗酸菌以外の
菌を殺菌し、均質なものとする第1工程。第1工程で調
整後の液をpH7付近の緩衝液で稀釈調整する第2工
程。第2工程処理液10ミリリットルに対し、ポリ塩化
アルミニウムを主剤とする第1凝集剤の25乃至50%
水溶液、硫酸アルミニウム、アンモニウムミョウバン、
カリミョウバン、硫酸第一鉄、硫酸第二鉄の一種よりな
る第2凝集剤の0.5乃至10%水溶液、アニオン系、
ノニオン系、カチオン系の少なくとも一種よりなる高分
子有機凝集剤の0.05乃至0.3%水溶液の三種の水
溶液のうちの少なくとも一種の水溶液を0.01乃至
0.05ミリリットルの割合で加え、撹拌し暫時後、1
300×g乃至1800×gの遠心力で約25分乃至1
5分間遠心分離を行い、沈渣物中より目的の抗酸菌を回
収することを特徴とする抗酸菌回収方法。7. A first step in which sputum presumed to contain acid-fast bacteria is used as a sample solution, and bacteria other than the acid-fast bacteria are sterilized with a disinfectant such as an alkali to make the solution homogeneous. A second step of diluting and adjusting the solution adjusted in the first step with a buffer solution having a pH of about 7. 25 to 50% of the first flocculant containing polyaluminum chloride as the main component per 10 ml of the second process liquid
Aqueous solution, aluminum sulfate, ammonium alum,
0.5-10% aqueous solution of a second aggregating agent comprising a kind of alum, ferrous sulfate, ferric sulfate, anionic,
Nonionic, at least one aqueous solution among three aqueous solutions of 0.05 to 0.3% aqueous solution of a high molecular organic coagulant comprising at least one of cationic type is added at a ratio of 0.01 to 0.05 ml; After stirring for a while, 1
About 25 minutes to 1 at a centrifugal force of 300 xg to 1800 xg
A method for recovering an acid-fast bacterium, comprising centrifuging for 5 minutes and recovering a target acid-fast bacterium from a sediment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27823799A JP2001095559A (en) | 1999-09-30 | 1999-09-30 | Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27823799A JP2001095559A (en) | 1999-09-30 | 1999-09-30 | Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001095559A true JP2001095559A (en) | 2001-04-10 |
Family
ID=17594540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27823799A Pending JP2001095559A (en) | 1999-09-30 | 1999-09-30 | Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001095559A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2421919A (en) * | 2005-01-08 | 2006-07-12 | Mem Teq Ventures Ltd | Method of separating microbes |
WO2013059754A1 (en) * | 2011-10-20 | 2013-04-25 | Board Of Regents, The University Of Texas System | Continuous flocculation deflocculation process for efficient harvesting of microalgae from aqueous solutions |
CN105899933A (en) * | 2013-10-29 | 2016-08-24 | 艾德克斯实验室公司 | Method and device for detecting bacteria and determining the concentration thereof in a liquid sample |
-
1999
- 1999-09-30 JP JP27823799A patent/JP2001095559A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2421919A (en) * | 2005-01-08 | 2006-07-12 | Mem Teq Ventures Ltd | Method of separating microbes |
WO2013059754A1 (en) * | 2011-10-20 | 2013-04-25 | Board Of Regents, The University Of Texas System | Continuous flocculation deflocculation process for efficient harvesting of microalgae from aqueous solutions |
CN105899933A (en) * | 2013-10-29 | 2016-08-24 | 艾德克斯实验室公司 | Method and device for detecting bacteria and determining the concentration thereof in a liquid sample |
JP2017500884A (en) * | 2013-10-29 | 2017-01-12 | アイデックス ラボラトリーズ インコーポレイテッドIDEXX Laboratories, Inc. | Method and container for detecting bacteria in a liquid sample and determining their concentration |
US10359352B2 (en) | 2013-10-29 | 2019-07-23 | Idexx Laboratories, Inc. | Method and device for detecting bacteria and determining the concentration thereof in a liquid sample |
US10914670B2 (en) | 2013-10-29 | 2021-02-09 | Idexx Laboratories, Inc. | Method and device for detecting bacteria and determining the concentration thereof in a liquid sample |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McFeters et al. | Comparative survival of indicator bacteria and enteric pathogens in well water | |
Moe et al. | Observations on the ultrastructure and viability of the cystic stage of Blastocystis hominis from human feces | |
KR101509139B1 (en) | Method for purifying hyaluronic acid | |
James et al. | Attachment of gonococci to sperm. Influence of physical and chemical factors. | |
CN105132302B (en) | A kind of application of waxy Bacillus in handling leather-making waste water COD | |
Armon et al. | A simple, rapid and sensitive presence/absence detection test for bacteriophage in drinking water | |
CN109706096A (en) | One plant of brevibacterium frigoritolerans and its application with denitrogenation and efficient flocculating ability | |
JP4260244B2 (en) | Bacterial cell concentration reagent | |
JPWO2004055170A1 (en) | Microorganism or cell collection method and microorganism or cell collection tool used therefor | |
JP2001095559A (en) | Assisting agent for centrifugal collection of microorganism, recovery of microorganism and recovery of acid-fast microorganism | |
Hopper et al. | A flotation process for water purification | |
JP3228315B2 (en) | Method for reducing the viable count of xanthan gum | |
JP2608459B2 (en) | Waste liquid treatment method | |
JP4260309B2 (en) | Acid-fast bacterium cell concentration reagent, kit, and acid-fast bacterium cell concentration method | |
JP7329912B2 (en) | Microorganism detection method | |
JP2021079381A (en) | Bacillus dominance apparatus, method for relative evaluation of the amount of bacillus bacteria, and wastewater treatment method using the same | |
RU2141665C1 (en) | Method of detection of tuberculosis mycobacterium | |
CN111424000A (en) | Method for rapidly separating Geobacillus stearothermophilus spores and vegetative thalli | |
WO2020085420A1 (en) | Cell collection method | |
Yuksek et al. | Examination of Helicobacter pylori DNA in tap waters and bottled drinking waters | |
JPH11164698A (en) | Detection of legionella in floc | |
CN115011480B (en) | Method for separating microorganism from animal tissue and application thereof | |
Halls et al. | The microbial associations developing on experimental trickling filters irrigated with domestic sewage | |
CN112805388A (en) | Method for detecting microorganism | |
JP4083860B2 (en) | Use of alcohol-salt buffer wash for efficient recovery of mycobacteria and mycobacterial DNA from respiratory sediments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051216 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060522 |